Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service hysterectomy, hysteroscopy & ablation cases in South Dakota: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 3% on average (238 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 4 | 348 | 23% |
| 2020 | 4 | 310 | 25% |
| 2021 | 4 | 379 | 28% |
| 2022 | 3 | 346 | 32% |
| 2023 | 3 | 327 | 36% |
| 2024 | 2 | 342 | 39% |
| 2025 from claims | – | 334 270–392 | 41% |
| 2026 forecast | – | 355 278–446 | 39% |
| 2027 forecast | – | 362 268–478 | 39% |
| 2028 forecast | – | 369 261–509 | 39% |
| 2029 forecast | – | 376 256–539 | 40% |
| 2030 forecast | – | 384 251–569 | 40% |
Laparoscopic/robotic hysterectomy, hysteroscopic resection, endometrial ablation. Professional codes (what the surgeon bills): CPT 58571, 58573, 58558, 58563, 58353, 58356, 58661, 58662.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in South Dakota; 1 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 4% inpatient hospital, 96% hospital outpatient.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Illinois | 30 | 3,307−3.1%/yr | −3.1%/yr | 2.6 | 12% | 3,820 in 2030+2.4%/yr |
| Ohio | 26 | 3,124−0.8%/yr | −0.8%/yr | 3.1 | 7% | 3,530 in 2030+2%/yr |
| Michigan | 15 | 2,577−6%/yr | −6%/yr | 3.4 | 11% | 2,550 in 2030−0.1%/yr |
| Indiana | 18 | 2,015−2.6%/yr | −2.6%/yr | 3.1 | 13% | 2,050 in 2030+0.2%/yr |
| Missouri | 13 | 1,625−3.4%/yr | −3.4%/yr | 2.9 | 10% | 1,650 in 2030+0.2%/yr |
| Wisconsin | 12 | 1,602−0.7%/yr | −0.7%/yr | 3.1 | 7% | 1,910 in 2030+3%/yr |
| Minnesota | 18 | 1,547−1%/yr | −1%/yr | 3.8 | 9% | 2,280 in 2030+6.7%/yr |
| Iowa | 12 | 908−1.5%/yr | −1.5%/yr | 2.2 | 11% | 880 in 2030−0.4%/yr |
| Kansas | 14 | 868−1.5%/yr | −1.5%/yr | 2.3 | 11% | 890 in 2030+0.4%/yr |
| Nebraska | 4 | 529−3.8%/yr | −3.8%/yr | 2.2 | 9% | 650 in 2030+3.6%/yr |
| North Dakota | 1 | 216−1.3%/yr | −1.3%/yr | 2.3 | 10% | 220 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 12 | 636+8.3%/yr | +8.3%/yr | 4.91.1× | 4% | 580 in 2030−1.6%/yr |
| Kidney stone management | 18 | 618+1.8%/yr | +1.8%/yr | 4.80.9× | 0% | 810 in 2030+4.6%/yr |
| Incontinence, prolapse & sacral neuromodulation | 4 | 4160%/yr | 0%/yr | 3.21.4× | 0% | 540 in 2030+4.4%/yr |
| Prostatectomy & nephrectomy | 8 | 299+3.3%/yr | +3.3%/yr | 2.51.8× | 0% | 560 in 2030+11%/yr |
Hysterectomy, hysteroscopy & ablation in every state, and its device makers · Every procedure market in South Dakota · Every state · Compare with Illinois
Hologic Sales And Service leads with 100% of company spending on these surgeons in 2025, +25 pts on 2024.
In 2025, 1 company reported engagement with South Dakota’s surgeons worth $520 in consulting, speaking, meals and travel tied to these products, about $260 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 14 clearances and approvals in the category, 3 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.